SCHEMBL11343138

SCHEMBL11343138

Cc1cc(C(=O)Nc2ccc3cc(S(=O)(=O)O)c(O)cc3c2)ccc1NC(=O)Nc1ccc(C(=O)Nc2ccc3cc(S(=O)(=O)O)c(O)cc3c2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPSE Q9Y251 2/20 0.46
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ TIMP3 P35625 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ USP2 O75604 2/20 0.43
▸ RECQL P46063 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ PRMT1 Q99873 2/20 0.43
▸ ENPP3 O14638 1/20 0.43
▸ ENTPD3 O75355 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ PRKD3 O94806 1/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ CBX7 O95931 1/20 0.43
▸ NSD2 O96028 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ PRKCG P05129 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10909166 0.94 ENPP2 (0.43) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11427500 0.86 ENPP2 (0.49) MEN1KMT2AMAPTTDP1ENPP2
SCHEMBL11351056 0.85 TIMP3 (0.52) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11342360 0.85 HPSE (0.48) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11339168 0.84 NT5E (0.58) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11435634 0.83 ENPP2 (0.47) MEN1KMT2AMAPTTDP1ENPP2
SCHEMBL11338942 0.83 HPSE (0.52) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11342692 0.83 ENPP2 (0.50) HPSEMEN1KMT2ATIMP3MAPT
SCHEMBL11432085 0.82 MEN1 (0.55) MEN1KMT2AMAPTTDP1NPC1
SCHEMBL11344749 0.82 MEN1 (0.53) HPSEMEN1KMT2ATIMP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback